Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in J Subst Abuse Treat

Retrieve available abstracts of 45 articles:
HTML format

Single Articles

    May 2021
  1. ZUBIAGO J, Murphy M, Guardado R, Daudelin D, et al
    Increased HIV testing in people who use drugs hospitalized in the first wave of the COVID-19 pandemic.
    J Subst Abuse Treat. 2021;124:108266.
    PubMed     Abstract available

  2. MEHTANI NJ, Ristau JT, Eveland J
    COVID-19: Broadening the horizons of U.S. harm reduction practices through managed alcohol programs.
    J Subst Abuse Treat. 2021;124:108225.

    April 2021
  3. MCGEOUGH BL, Karriker-Jaffe KJ, Zemore SE
    Rates and predictors of Alcoholics Anonymous attendance across sexual orientations.
    J Subst Abuse Treat. 2021;129:108400.
    PubMed     Abstract available

    February 2021
  4. BENSLEY KMK, Karriker-Jaffe KJ, Cherpitel C, Li L, et al
    Limited treatment accessibility: Implications for alcohol treatment disparities among Mexican Americans living in the U.S.-Mexico border region.
    J Subst Abuse Treat. 2021;121:108162.
    PubMed     Abstract available

    August 2020
  5. RICHARDSON GB, Smith R, Lowe L, Acquavita SP, et al
    Structure and longitudinal invariance of the Short Alcohol and Alcohol Problems Perception Questionnaire.
    J Subst Abuse Treat. 2020;115:108041.
    PubMed     Abstract available

    February 2020
  6. OLDFIELD BJ, McGinnis KA, Edelman EJ, Williams EC, et al
    Predictors of initiation of and retention on medications for alcohol use disorder among people living with and without HIV.
    J Subst Abuse Treat. 2020;109:14-22.
    PubMed     Abstract available

    September 2019
  7. STEWART SH, Walitzer KS, Blanco J, Swiatek D, et al
    Medication-enhanced behavior therapy for alcohol use disorder: Naltrexone, Alcoholics Anonymous Facilitation, and OPRM1 genetic variation.
    J Subst Abuse Treat. 2019;104:7-14.
    PubMed     Abstract available

    July 2019
  8. MELLOR R, Lancaster K, Ritter A
    Systematic review of untreated remission from alcohol problems: Estimation lies in the eye of the beholder.
    J Subst Abuse Treat. 2019;102:60-72.
    PubMed     Abstract available

    May 2019
  9. ZGIERSKA AE, Burzinski CA, Mundt MP, McClintock AS, et al
    Mindfulness-based relapse prevention for alcohol dependence: Findings from a randomized controlled trial.
    J Subst Abuse Treat. 2019;100:8-17.
    PubMed     Abstract available

    April 2019
  10. SYMONS M, Feeney GFX, Gallagher MR, Young RM, et al
    Machine learning vs addiction therapists: A pilot study predicting alcohol dependence treatment outcome from patient data in behavior therapy with adjunctive medication.
    J Subst Abuse Treat. 2019;99:156-162.
    PubMed     Abstract available

    November 2018
  11. ROBERTS W, Ralevski E, Verplaetse TL, McKee SA, et al
    Tobacco use during a clinical trial of mecamylamine for alcohol dependence: Medication effects on smoking and associations with reductions in drinking.
    J Subst Abuse Treat. 2018;94:91-96.
    PubMed     Abstract available

    June 2018
  12. MURPHY CM, Ting LA, Jordan LC, Musser PH, et al
    A randomized clinical trial of motivational enhancement therapy for alcohol problems in partner violent men.
    J Subst Abuse Treat. 2018;89:11-19.
    PubMed     Abstract available

    January 2018
  13. KRAMER SCHMIDT L, Bojesen AB, Nielsen AS, Andersen K, et al
    Duration of therapy - Does it matter?: A systematic review and meta-regression of the duration of psychosocial treatments for alcohol use disorder.
    J Subst Abuse Treat. 2018;84:57-67.
    PubMed     Abstract available

    November 2017
  14. WELCH-LAZORITZ M, Hautala D, Habecker P, Dombrowski K, et al
    Association between alcohol consumption and injection and sexual risk behaviors among people who inject drugs in rural Puerto Rico.
    J Subst Abuse Treat. 2017;82:34-40.
    PubMed     Abstract available

    September 2017
  15. ABRANTES AM, Blevins CE, Battle CL, Read JP, et al
    Developing a Fitbit-supported lifestyle physical activity intervention for depressed alcohol dependent women.
    J Subst Abuse Treat. 2017;80:88-97.
    PubMed     Abstract available

    June 2017
  16. ZWEBEN A, Piepmeier ME, Fucito L, O'Malley SS, et al
    The clinical utility of the Medication Adherence Questionnaire (MAQ) in an alcohol pharmacotherapy trial.
    J Subst Abuse Treat. 2017;77:72-78.
    PubMed     Abstract available

  17. GLASS JE, McKay JR, Gustafson DH, Kornfield R, et al
    Treatment seeking as a mechanism of change in a randomized controlled trial of a mobile health intervention to support recovery from alcohol use disorders.
    J Subst Abuse Treat. 2017;77:57-66.
    PubMed     Abstract available

  18. CHI FW, Weisner CM, Mertens JR, Ross TB, et al
    Alcohol brief intervention in primary care: Blood pressure outcomes in hypertensive patients.
    J Subst Abuse Treat. 2017;77:45-51.
    PubMed     Abstract available

  19. FINLAY AK, Ellerbe LS, Wong JJ, Timko C, et al
    Barriers to and facilitators of pharmacotherapy for alcohol use disorder in VA residential treatment programs.
    J Subst Abuse Treat. 2017;77:38-43.
    PubMed     Abstract available

  20. KUERBIS AN, Hail L, Moore AA, Muench FJ, et al
    A pilot study of online feedback for adult drinkers 50 and older: Feasibility, efficacy, and preferences for intervention.
    J Subst Abuse Treat. 2017;77:126-132.
    PubMed     Abstract available

  21. SKELTON E, Tzelepis F, Shakeshaft A, Guillaumier A, et al
    Smoking cessation care provision in Australian alcohol and other drug treatment services: A cross-sectional survey of staff self-reported practices.
    J Subst Abuse Treat. 2017;77:101-106.
    PubMed     Abstract available

  22. MOSTAFA H, Amin AM, Teh CH, Murugaiyah VA, et al
    Plasma metabolic biomarkers for discriminating individuals with alcohol use disorders from social drinkers and alcohol-naive subjects.
    J Subst Abuse Treat. 2017;77:1-5.
    PubMed     Abstract available

  23. CHOI NG, DiNitto DM, Marti CN
    Older adults who use or have used marijuana: Help-seeking for marijuana and other substance use problems.
    J Subst Abuse Treat. 2017;77:185-192.
    PubMed     Abstract available

    May 2017
  24. TUCKER JS, D'Amico EJ, Ewing BA, Miles JN, et al
    A group-based motivational interviewing brief intervention to reduce substance use and sexual risk behavior among homeless young adults.
    J Subst Abuse Treat. 2017;76:20-27.
    PubMed     Abstract available

  25. HEPNER KA, Watkins KE, Farmer CM, Rubenstein L, et al
    Quality of care measures for the management of unhealthy alcohol use.
    J Subst Abuse Treat. 2017;76:11-17.
    PubMed     Abstract available

  26. SCHWARTZ RP, McNeely J, Wu LT, Sharma G, et al
    Identifying substance misuse in primary care: TAPS Tool compared to the WHO ASSIST.
    J Subst Abuse Treat. 2017;76:69-76.
    PubMed     Abstract available

  27. HAGEN E, Erga AH, Hagen KP, Nesvag SM, et al
    One-year sobriety improves satisfaction with life, executive functions and psychological distress among patients with polysubstance use disorder.
    J Subst Abuse Treat. 2017;76:81-87.
    PubMed     Abstract available

    April 2017
  28. VERISSIMO AD, Grella CE
    Influence of gender and race/ethnicity on perceived barriers to help-seeking for alcohol or drug problems.
    J Subst Abuse Treat. 2017;75:54-61.
    PubMed     Abstract available

  29. HOLZHAUER CG, Epstein EE, Cohn AM, McCrady BS, et al
    Heterogeneity in pathways to abstinence among women in treatment for alcohol use disorder.
    J Subst Abuse Treat. 2017;75:1-9.
    PubMed     Abstract available

    March 2017
  30. MORLEY KC, Logge W, Pearson SA, Baillie A, et al
    Socioeconomic and geographic disparities in access to pharmacotherapy for alcohol dependence.
    J Subst Abuse Treat. 2017;74:23-25.
    PubMed     Abstract available

  31. PRENDERGAST ML, McCollister K, Warda U
    A randomized study of the use of screening, brief intervention, and referral to treatment (SBIRT) for drug and alcohol use with jail inmates.
    J Subst Abuse Treat. 2017;74:54-64.
    PubMed     Abstract available

    February 2017
  32. MACKIE SE, McHugh RK, McDermott K, Griffin ML, et al
    Prevalence of restless legs syndrome during detoxification from alcohol and opioids.
    J Subst Abuse Treat. 2017;73:35-39.
    PubMed     Abstract available

  33. BENSLEY KM, Harris AH, Gupta S, Rubinsky AD, et al
    Racial/ethnic differences in initiation of and engagement with addictions treatment among patients with alcohol use disorders in the veterans health administration.
    J Subst Abuse Treat. 2017;73:27-34.
    PubMed     Abstract available

  34. ZEMORE SE, Kaskutas LA, Mericle A, Hemberg J, et al
    Comparison of 12-step groups to mutual help alternatives for AUD in a large, national study: Differences in membership characteristics and group participation, cohesion, and satisfaction.
    J Subst Abuse Treat. 2017;73:16-26.
    PubMed     Abstract available

  35. BORSARI B, Apodaca TR, Yurasek A, Monti PM, et al
    Does mental status impact therapist and patient communication in emergency department brief interventions addressing alcohol use?
    J Subst Abuse Treat. 2017;73:1-8.
    PubMed     Abstract available

    January 2017
  36. COONEY JL, Cooper S, Grant C, Sevarino K, et al
    A Randomized Trial of Contingency Management for Smoking Cessation During Intensive Outpatient Alcohol Treatment.
    J Subst Abuse Treat. 2017;72:89-96.
    PubMed     Abstract available

    May 2016
  37. HU X, Harman J, Winterstein AG, Zhong Y, et al
    Utilization of Alcohol Treatment Among HIV-Positive Women with Hazardous Drinking.
    J Subst Abuse Treat. 2016;64:55-61.
    PubMed     Abstract available

  38. BOURKE E, Magill M, Apodaca TR
    The In-Session and Long-Term Role of a Significant Other in Motivational Enhancement Therapy for Alcohol Use Disorders.
    J Subst Abuse Treat. 2016;64:35-43.
    PubMed     Abstract available

    April 2016
  39. MAGILL M, R Apodaca T, Karno M, Gaume J, et al
    Reliability and Validity of an Observational Measure of Client Decision-Making: The Client Language Assessment - Proximal/Distal (CLA-PD).
    J Subst Abuse Treat. 2016;63:10-7.
    PubMed     Abstract available

    March 2016
  40. KNUDSEN HK, Roman PM
    The Diffusion of Acamprosate for the Treatment of Alcohol Use Disorder: Results From a National Longitudinal Study.
    J Subst Abuse Treat. 2016;62:62-7.
    PubMed     Abstract available

  41. ALANIS-HIRSCH K, Croff R, Ford JH 2nd, Johnson K, et al
    Extended-Release Naltrexone: A Qualitative Analysis of Barriers to Routine Use.
    J Subst Abuse Treat. 2016;62:68-73.
    PubMed     Abstract available

    February 2016
  42. LANDY MS, Davey CJ, Quintero D, Pecora A, et al
    A Systematic Review on the Effectiveness of Brief Interventions for Alcohol Misuse among Adults in Emergency Departments.
    J Subst Abuse Treat. 2016;61:1-12.
    PubMed     Abstract available

    January 2016
  43. WILLIAMS EC, Achtmeyer CE, Young JP, Rittmueller SE, et al
    Local Implementation of Alcohol Screening and Brief Intervention at Five Veterans Health Administration Primary Care Clinics: Perspectives of Clinical and Administrative Staff.
    J Subst Abuse Treat. 2016;60:27-35.
    PubMed     Abstract available

  44. BARNES AJ, Xu H, Tseng CH, Ang A, et al
    The Effect of a Patient-Provider Educational Intervention to Reduce At-Risk Drinking on Changes in Health and Health-Related Quality of Life Among Older Adults: The Project SHARE Study.
    J Subst Abuse Treat. 2016;60:14-20.
    PubMed     Abstract available

  45. DARNELL D, Dunn C, Atkins D, Ingraham L, et al
    A Randomized Evaluation of Motivational Interviewing Training for Mandated Implementation of Alcohol Screening and Brief Intervention in Trauma Centers.
    J Subst Abuse Treat. 2016;60:36-44.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Alcoholism is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.